Robert Bowdring is the Chief Financial Officer of Dynasil Corporation. Rob is the steward of Dynasil’s financial health, overseeing the finance and regulatory reporting functions across the whole corporation. Prior to becoming Chief Financial Officer in 2016, he served as Corporate Controller from 2013 to 2016.
Rob came to Dynasil from INVO Bioscience where he was the Chief Financial Officer from 2008 to 2013. INVO Bioscience is a publicly traded development stage medical device company bringing its technology through FDA approval. He continues to sit on the Board of Directors of INVO Bioscience. From 2003 to 2008, he was Chief Financial Officer of Cyphermint Inc., a provider of SaaS solutions to the mobile telecom industry. From 1989 to 2003, he served as Vice President and Corporate Controller for Lifeline Systems, a service provider of personal response systems for hospitals.
Earlier in his career, he held Controller and Vice President positions at Remanco Inc., Warburton’s Inc., Cyborg Corporation, and Technogenics, Inc.
Rob has a B.A. in accounting from the University of Massachusetts.